BioVaxys Technology Corp. (BIOV.CN)
CAD 0.06
(0.0%)
CAD 0.06
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.4 Million CAD | -41.14% |
| 2022 | 4.08 Million CAD | -36.64% |
| 2021 | 6.44 Million CAD | 486.5% |
| 2020 | 1.09 Million CAD | 377.75% |
| 2019 | 229.9 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 370.7 Thousand CAD | -91.16% |
| 2024 Q3 | 802.18 Thousand CAD | 48.78% |
| 2024 Q2 | 539.18 Thousand CAD | 45.45% |
| 2023 Q2 | 782.8 Thousand CAD | -14.45% |
| 2023 Q1 | 915.06 Thousand CAD | -0.96% |
| 2023 FY | 6.45 Million CAD | 58.1% |
| 2023 Q4 | 4.19 Million CAD | 645.8% |
| 2023 Q3 | 562.22 Thousand CAD | -28.18% |
| 2022 Q1 | 1.2 Million CAD | -51.95% |
| 2022 Q4 | 923.95 Thousand CAD | 1.6% |
| 2022 FY | 4.08 Million CAD | -36.64% |
| 2022 Q3 | 909.43 Thousand CAD | -12.55% |
| 2022 Q2 | 1.04 Million CAD | -13.93% |
| 2021 Q4 | 2.51 Million CAD | 181.52% |
| 2021 FY | 6.44 Million CAD | 486.5% |
| 2021 Q1 | 1.53 Million CAD | 91.76% |
| 2021 Q3 | 893.39 Thousand CAD | -40.27% |
| 2021 Q2 | 1.49 Million CAD | -2.75% |
| 2020 Q2 | 65.41 Thousand CAD | 94.64% |
| 2020 Q1 | 33.6 Thousand CAD | -50.49% |
| 2020 FY | 1.09 Million CAD | 377.75% |
| 2020 Q4 | 802.03 Thousand CAD | 306.44% |
| 2020 Q3 | 197.33 Thousand CAD | 201.65% |
| 2019 Q3 | 37.81 Thousand CAD | -35.65% |
| 2019 Q1 | 65.44 Thousand CAD | -49.77% |
| 2019 Q4 | 67.88 Thousand CAD | 79.53% |
| 2019 Q2 | 58.76 Thousand CAD | -10.21% |
| 2019 FY | 229.9 Thousand CAD | 0.0% |
| 2018 Q4 | 130.28 Thousand CAD | 321.14% |
| 2018 Q3 | 30.93 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 5.19 Million CAD | 53.721% |
| Asep Medical Holdings Inc | 7.74 Million CAD | 68.968% |
| BetterLife Pharma Inc. | 3.24 Million CAD | 25.851% |
| ChitogenX Inc. | 2.83 Million CAD | 15.102% |
| Rapid Dose Therapeutics Corp. | 4.2 Million CAD | 42.91% |
| Defence Therapeutics Inc. | 12.65 Million CAD | 81.016% |
| Entheon Biomedical Corp. | 564.31 Thousand CAD | -325.755% |
| Gemina Laboratories Ltd. | 5.08 Million CAD | 52.759% |
| Glow Lifetech Corp. | 25.71 Thousand CAD | -9243.193% |
| Lexston Life Sciences Corp. | 674.71 Thousand CAD | -256.09% |
| Pharmala Biotech Holdings Inc. | 1.21 Million CAD | -97.412% |
| Doseology Sciences Inc. | 72.08 Thousand CAD | -3232.92% |
| MYND Life Sciences Inc. | 1.47 Million CAD | -62.912% |
| Nova Mentis Life Science Corp. | 1.2 Million CAD | -99.834% |
| PharmaTher Holdings Ltd. | 3.04 Million CAD | 21.073% |
| PreveCeutical Medical Inc. | 963.12 Thousand CAD | -149.459% |
| Telescope Innovations Corp. | 6.35 Million CAD | 62.177% |